nodes	percent_of_prediction	percent_of_DWPC	metapath
Arsenic trioxide—CYP1A1—Dacarbazine—muscle cancer	0.114	0.197	CbGbCtD
Arsenic trioxide—CYP1B1—Doxorubicin—muscle cancer	0.0868	0.15	CbGbCtD
Arsenic trioxide—ABCC2—Vincristine—muscle cancer	0.0731	0.126	CbGbCtD
Arsenic trioxide—ABCC2—Etoposide—muscle cancer	0.0669	0.115	CbGbCtD
Arsenic trioxide—ABCC2—Doxorubicin—muscle cancer	0.0457	0.0786	CbGbCtD
Arsenic trioxide—ABCC2—Methotrexate—muscle cancer	0.0442	0.0762	CbGbCtD
Arsenic trioxide—ABCB1—Dactinomycin—muscle cancer	0.0387	0.0666	CbGbCtD
Arsenic trioxide—ABCB1—Vincristine—muscle cancer	0.0238	0.041	CbGbCtD
Arsenic trioxide—ABCB1—Etoposide—muscle cancer	0.0218	0.0376	CbGbCtD
Arsenic trioxide—CCND1—larynx—muscle cancer	0.0172	0.112	CbGeAlD
Arsenic trioxide—ABCB1—Doxorubicin—muscle cancer	0.0149	0.0256	CbGbCtD
Arsenic trioxide—ABCB1—Methotrexate—muscle cancer	0.0144	0.0248	CbGbCtD
Arsenic trioxide—CYP3A4—Vincristine—muscle cancer	0.0143	0.0246	CbGbCtD
Arsenic trioxide—CYP3A4—Etoposide—muscle cancer	0.0131	0.0225	CbGbCtD
Arsenic trioxide—AKT1—hindlimb—muscle cancer	0.00939	0.0614	CbGeAlD
Arsenic trioxide—CYP3A4—Doxorubicin—muscle cancer	0.00892	0.0154	CbGbCtD
Arsenic trioxide—AKT1—appendage—muscle cancer	0.00806	0.0526	CbGeAlD
Arsenic trioxide—CCND1—embryo—muscle cancer	0.00381	0.0249	CbGeAlD
Arsenic trioxide—MAPK1—embryo—muscle cancer	0.00321	0.0209	CbGeAlD
Arsenic trioxide—CCND1—smooth muscle tissue—muscle cancer	0.00299	0.0195	CbGeAlD
Arsenic trioxide—TXNRD1—Teniposide—Etoposide—muscle cancer	0.00292	0.509	CbGdCrCtD
Arsenic trioxide—CCND1—renal system—muscle cancer	0.00288	0.0188	CbGeAlD
Arsenic trioxide—MAPK3—embryo—muscle cancer	0.00284	0.0185	CbGeAlD
Arsenic trioxide—AKT1—embryo—muscle cancer	0.00268	0.0175	CbGeAlD
Arsenic trioxide—CCND1—cardiac atrium—muscle cancer	0.00258	0.0168	CbGeAlD
Arsenic trioxide—MAPK1—smooth muscle tissue—muscle cancer	0.00252	0.0165	CbGeAlD
Arsenic trioxide—MAPK1—renal system—muscle cancer	0.00243	0.0159	CbGeAlD
Arsenic trioxide—TXNRD1—smooth muscle tissue—muscle cancer	0.00235	0.0153	CbGeAlD
Arsenic trioxide—JUN—embryo—muscle cancer	0.00233	0.0152	CbGeAlD
Arsenic trioxide—IKBKB—embryo—muscle cancer	0.00232	0.0151	CbGeAlD
Arsenic trioxide—TXNRD1—renal system—muscle cancer	0.00226	0.0148	CbGeAlD
Arsenic trioxide—CCND1—tendon—muscle cancer	0.00225	0.0147	CbGeAlD
Arsenic trioxide—MAPK3—smooth muscle tissue—muscle cancer	0.00223	0.0146	CbGeAlD
Arsenic trioxide—MAPK1—cardiac atrium—muscle cancer	0.00217	0.0142	CbGeAlD
Arsenic trioxide—MAPK3—renal system—muscle cancer	0.00215	0.014	CbGeAlD
Arsenic trioxide—AKT1—smooth muscle tissue—muscle cancer	0.0021	0.0137	CbGeAlD
Arsenic trioxide—CCND1—vagina—muscle cancer	0.00209	0.0136	CbGeAlD
Arsenic trioxide—AKT1—renal system—muscle cancer	0.00203	0.0132	CbGeAlD
Arsenic trioxide—TXNRD1—cardiac atrium—muscle cancer	0.00202	0.0132	CbGeAlD
Arsenic trioxide—CCND1—head—muscle cancer	0.00193	0.0126	CbGeAlD
Arsenic trioxide—MAPK3—cardiac atrium—muscle cancer	0.00192	0.0126	CbGeAlD
Arsenic trioxide—CCND1—testis—muscle cancer	0.00186	0.0122	CbGeAlD
Arsenic trioxide—MAPK1—bone marrow—muscle cancer	0.00183	0.012	CbGeAlD
Arsenic trioxide—JUN—smooth muscle tissue—muscle cancer	0.00183	0.012	CbGeAlD
Arsenic trioxide—IKBKB—smooth muscle tissue—muscle cancer	0.00182	0.0119	CbGeAlD
Arsenic trioxide—AKT1—cardiac atrium—muscle cancer	0.00181	0.0118	CbGeAlD
Arsenic trioxide—TXNRD1—tendon—muscle cancer	0.00176	0.0115	CbGeAlD
Arsenic trioxide—JUN—renal system—muscle cancer	0.00176	0.0115	CbGeAlD
Arsenic trioxide—MAPK1—vagina—muscle cancer	0.00176	0.0115	CbGeAlD
Arsenic trioxide—TXNRD1—bone marrow—muscle cancer	0.00171	0.0112	CbGeAlD
Arsenic trioxide—MAPK3—tendon—muscle cancer	0.00168	0.011	CbGeAlD
Arsenic trioxide—TXNRD1—vagina—muscle cancer	0.00164	0.0107	CbGeAlD
Arsenic trioxide—MAPK3—bone marrow—muscle cancer	0.00162	0.0106	CbGeAlD
Arsenic trioxide—MAPK1—head—muscle cancer	0.00162	0.0106	CbGeAlD
Arsenic trioxide—AKT1—tendon—muscle cancer	0.00158	0.0103	CbGeAlD
Arsenic trioxide—JUN—cardiac atrium—muscle cancer	0.00158	0.0103	CbGeAlD
Arsenic trioxide—MAPK1—testis—muscle cancer	0.00157	0.0102	CbGeAlD
Arsenic trioxide—MAPK3—vagina—muscle cancer	0.00156	0.0102	CbGeAlD
Arsenic trioxide—AKT1—bone marrow—muscle cancer	0.00153	0.01	CbGeAlD
Arsenic trioxide—TXNRD1—head—muscle cancer	0.00151	0.00987	CbGeAlD
Arsenic trioxide—AKT1—vagina—muscle cancer	0.00147	0.00958	CbGeAlD
Arsenic trioxide—TXNRD1—testis—muscle cancer	0.00146	0.00954	CbGeAlD
Arsenic trioxide—MAPK3—head—muscle cancer	0.00144	0.00939	CbGeAlD
Arsenic trioxide—TXNRD1—Idarubicin—Doxorubicin—muscle cancer	0.00141	0.246	CbGdCrCtD
Arsenic trioxide—TXNRD1—Daunorubicin—Doxorubicin—muscle cancer	0.00141	0.246	CbGdCrCtD
Arsenic trioxide—MAPK3—testis—muscle cancer	0.00139	0.00907	CbGeAlD
Arsenic trioxide—JUN—tendon—muscle cancer	0.00138	0.00899	CbGeAlD
Arsenic trioxide—IKBKB—tendon—muscle cancer	0.00137	0.00895	CbGeAlD
Arsenic trioxide—AKT1—head—muscle cancer	0.00136	0.00885	CbGeAlD
Arsenic trioxide—JUN—bone marrow—muscle cancer	0.00133	0.00871	CbGeAlD
Arsenic trioxide—AKT1—testis—muscle cancer	0.00131	0.00855	CbGeAlD
Arsenic trioxide—JUN—vagina—muscle cancer	0.00128	0.00834	CbGeAlD
Arsenic trioxide—IKBKB—vagina—muscle cancer	0.00127	0.0083	CbGeAlD
Arsenic trioxide—JUN—head—muscle cancer	0.00118	0.0077	CbGeAlD
Arsenic trioxide—IKBKB—head—muscle cancer	0.00117	0.00767	CbGeAlD
Arsenic trioxide—JUN—testis—muscle cancer	0.00114	0.00744	CbGeAlD
Arsenic trioxide—IKBKB—testis—muscle cancer	0.00113	0.00741	CbGeAlD
Arsenic trioxide—CYP1B1—smooth muscle tissue—muscle cancer	0.000976	0.00638	CbGeAlD
Arsenic trioxide—ABCC2—renal system—muscle cancer	0.00096	0.00627	CbGeAlD
Arsenic trioxide—CYP1B1—renal system—muscle cancer	0.00094	0.00614	CbGeAlD
Arsenic trioxide—ABCC2—tendon—muscle cancer	0.000749	0.00489	CbGeAlD
Arsenic trioxide—CYP1B1—tendon—muscle cancer	0.000734	0.00479	CbGeAlD
Arsenic trioxide—CYP1A1—renal system—muscle cancer	0.000664	0.00434	CbGeAlD
Arsenic trioxide—CYP1B1—head—muscle cancer	0.000629	0.00411	CbGeAlD
Arsenic trioxide—ABCC2—testis—muscle cancer	0.00062	0.00405	CbGeAlD
Arsenic trioxide—CYP1B1—testis—muscle cancer	0.000607	0.00397	CbGeAlD
Arsenic trioxide—CYP1A1—cardiac atrium—muscle cancer	0.000595	0.00389	CbGeAlD
Arsenic trioxide—CYP3A4—renal system—muscle cancer	0.000488	0.00318	CbGeAlD
Arsenic trioxide—CYP1A1—vagina—muscle cancer	0.000481	0.00314	CbGeAlD
Arsenic trioxide—ABCB1—embryo—muscle cancer	0.000456	0.00298	CbGeAlD
Arsenic trioxide—CYP1A1—head—muscle cancer	0.000445	0.0029	CbGeAlD
Arsenic trioxide—ABCB1—renal system—muscle cancer	0.000345	0.00225	CbGeAlD
Arsenic trioxide—ABCB1—bone marrow—muscle cancer	0.000261	0.0017	CbGeAlD
Arsenic trioxide—ABCB1—vagina—muscle cancer	0.00025	0.00163	CbGeAlD
Arsenic trioxide—ABCB1—head—muscle cancer	0.000231	0.00151	CbGeAlD
Arsenic trioxide—ABCB1—testis—muscle cancer	0.000223	0.00146	CbGeAlD
Arsenic trioxide—MAPK1—Transmission across Chemical Synapses—MDM2—muscle cancer	8.49e-05	0.000326	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—PTCH1—muscle cancer	8.48e-05	0.000326	CbGpPWpGaD
Arsenic trioxide—JUN—Oxidative Stress Induced Senescence—TP53—muscle cancer	8.32e-05	0.00032	CbGpPWpGaD
Arsenic trioxide—MAPK1—NGF signalling via TRKA from the plasma membrane—MDM2—muscle cancer	8.29e-05	0.000318	CbGpPWpGaD
Arsenic trioxide—IKBKB—B Cell Activation—MDM2—muscle cancer	8.29e-05	0.000318	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—FOXO4—muscle cancer	8.21e-05	0.000315	CbGpPWpGaD
Arsenic trioxide—MAPK1—Senescence and Autophagy in Cancer—TP53—muscle cancer	8.16e-05	0.000313	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by NGF—KIT—muscle cancer	8.1e-05	0.000311	CbGpPWpGaD
Arsenic trioxide—MAPK1—Integrated Breast Cancer Pathway—VEGFA—muscle cancer	8.07e-05	0.00031	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—CD34—muscle cancer	7.93e-05	0.000305	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—FH—muscle cancer	7.93e-05	0.000304	CbGpPWpGaD
Arsenic trioxide—AKT1—Hemostasis—IGF2—muscle cancer	7.93e-05	0.000304	CbGpPWpGaD
Arsenic trioxide—MAPK1—DNA Damage Response (only ATM dependent)—TP53—muscle cancer	7.92e-05	0.000304	CbGpPWpGaD
Arsenic trioxide—JUN—Cellular responses to stress—CDKN2A—muscle cancer	7.9e-05	0.000304	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—FOXO4—muscle cancer	7.85e-05	0.000302	CbGpPWpGaD
Arsenic trioxide—MAPK3—Spinal Cord Injury—TP53—muscle cancer	7.81e-05	0.0003	CbGpPWpGaD
Arsenic trioxide—MAPK3—Oxidative Stress Induced Senescence—TP53—muscle cancer	7.75e-05	0.000298	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling by NGF—KIT—muscle cancer	7.75e-05	0.000297	CbGpPWpGaD
Arsenic trioxide—MAPK3—Hemostasis—IGF2—muscle cancer	7.69e-05	0.000295	CbGpPWpGaD
Arsenic trioxide—JUN—Cellular responses to stress—MDM2—muscle cancer	7.67e-05	0.000294	CbGpPWpGaD
Arsenic trioxide—JUN—TGF-beta Signaling Pathway—TP53—muscle cancer	7.66e-05	0.000294	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—CD34—muscle cancer	7.62e-05	0.000293	CbGpPWpGaD
Arsenic trioxide—JUN—Focal Adhesion—VEGFA—muscle cancer	7.57e-05	0.000291	CbGpPWpGaD
Arsenic trioxide—JUN—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	7.54e-05	0.00029	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—FOXO4—muscle cancer	7.54e-05	0.00029	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Tryptophan metabolism—MDM2—muscle cancer	7.51e-05	0.000288	CbGpPWpGaD
Arsenic trioxide—AKT1—Developmental Biology—FOXO1—muscle cancer	7.44e-05	0.000286	CbGpPWpGaD
Arsenic trioxide—MAPK1—Spinal Cord Injury—TP53—muscle cancer	7.43e-05	0.000285	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—CD34—muscle cancer	7.39e-05	0.000284	CbGpPWpGaD
Arsenic trioxide—MAPK1—Oxidative Stress Induced Senescence—TP53—muscle cancer	7.38e-05	0.000283	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cellular responses to stress—CDKN2A—muscle cancer	7.37e-05	0.000283	CbGpPWpGaD
Arsenic trioxide—AKT1—TGF-beta Signaling Pathway—TP53—muscle cancer	7.36e-05	0.000283	CbGpPWpGaD
Arsenic trioxide—MAPK1—Hemostasis—IGF2—muscle cancer	7.31e-05	0.000281	CbGpPWpGaD
Arsenic trioxide—JUN—Direct p53 effectors—TP53—muscle cancer	7.31e-05	0.000281	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—FOXO4—muscle cancer	7.29e-05	0.00028	CbGpPWpGaD
Arsenic trioxide—AKT1—Focal Adhesion—VEGFA—muscle cancer	7.28e-05	0.000279	CbGpPWpGaD
Arsenic trioxide—AKT1—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	7.25e-05	0.000278	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—FOXO1—muscle cancer	7.21e-05	0.000277	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—CNR1—muscle cancer	7.16e-05	0.000275	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cellular responses to stress—MDM2—muscle cancer	7.14e-05	0.000274	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—CD34—muscle cancer	7.03e-05	0.00027	CbGpPWpGaD
Arsenic trioxide—MAPK3—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	7.03e-05	0.00027	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cellular responses to stress—CDKN2A—muscle cancer	7.01e-05	0.000269	CbGpPWpGaD
Arsenic trioxide—ABCB1—HIF-1-alpha transcription factor network—VEGFA—muscle cancer	6.93e-05	0.000266	CbGpPWpGaD
Arsenic trioxide—AKT1—Gene Expression—MED12—muscle cancer	6.93e-05	0.000266	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by NGF—MDM2—muscle cancer	6.91e-05	0.000265	CbGpPWpGaD
Arsenic trioxide—JUN—Integrated Breast Cancer Pathway—TP53—muscle cancer	6.88e-05	0.000264	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—FOXO1—muscle cancer	6.86e-05	0.000264	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—FOXO1—muscle cancer	6.84e-05	0.000262	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cellular responses to stress—MDM2—muscle cancer	6.8e-05	0.000261	CbGpPWpGaD
Arsenic trioxide—MAPK1—TGF-beta Signaling Pathway—TP53—muscle cancer	6.79e-05	0.000261	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—CD34—muscle cancer	6.73e-05	0.000258	CbGpPWpGaD
Arsenic trioxide—MAPK3—Gene Expression—MED12—muscle cancer	6.72e-05	0.000258	CbGpPWpGaD
Arsenic trioxide—MAPK1—Focal Adhesion—VEGFA—muscle cancer	6.72e-05	0.000258	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by NGF—MDM2—muscle cancer	6.7e-05	0.000257	CbGpPWpGaD
Arsenic trioxide—MAPK1—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	6.69e-05	0.000257	CbGpPWpGaD
Arsenic trioxide—AKT1—Integrated Breast Cancer Pathway—TP53—muscle cancer	6.61e-05	0.000254	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—PTCH1—muscle cancer	6.59e-05	0.000253	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—FOXO1—muscle cancer	6.57e-05	0.000252	CbGpPWpGaD
Arsenic trioxide—MAPK1—Neuronal System—MDM2—muscle cancer	6.5e-05	0.00025	CbGpPWpGaD
Arsenic trioxide—AKT1—Apoptosis—TP53—muscle cancer	6.47e-05	0.000249	CbGpPWpGaD
Arsenic trioxide—AKT1—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	6.45e-05	0.000248	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—PTCH1—muscle cancer	6.39e-05	0.000246	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by NGF—MDM2—muscle cancer	6.38e-05	0.000245	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—FOXO1—muscle cancer	6.37e-05	0.000245	CbGpPWpGaD
Arsenic trioxide—JUN—MAPK Signaling Pathway—TP53—muscle cancer	6.32e-05	0.000243	CbGpPWpGaD
Arsenic trioxide—AKT1—Adaptive Immune System—FOXO1—muscle cancer	6.31e-05	0.000242	CbGpPWpGaD
Arsenic trioxide—MAPK3—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	6.25e-05	0.00024	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism of lipids and lipoproteins—MED12—muscle cancer	6.19e-05	0.000238	CbGpPWpGaD
Arsenic trioxide—AKT1—GPCR downstream signaling—CNR1—muscle cancer	6.13e-05	0.000235	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling by NGF—MDM2—muscle cancer	6.1e-05	0.000234	CbGpPWpGaD
Arsenic trioxide—MAPK1—Integrated Breast Cancer Pathway—TP53—muscle cancer	6.1e-05	0.000234	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—PTCH1—muscle cancer	6.08e-05	0.000234	CbGpPWpGaD
Arsenic trioxide—AKT1—MAPK Signaling Pathway—TP53—muscle cancer	6.07e-05	0.000233	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—FOXO1—muscle cancer	6.06e-05	0.000233	CbGpPWpGaD
Arsenic trioxide—ABCB1—Allograft Rejection—VEGFA—muscle cancer	6e-05	0.000231	CbGpPWpGaD
Arsenic trioxide—MAPK1—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	5.95e-05	0.000229	CbGpPWpGaD
Arsenic trioxide—MAPK3—MAPK Signaling Pathway—TP53—muscle cancer	5.89e-05	0.000226	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—ENO2—muscle cancer	5.87e-05	0.000225	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—IGF2—muscle cancer	5.85e-05	0.000225	CbGpPWpGaD
Arsenic trioxide—JUN—Cellular responses to stress—VEGFA—muscle cancer	5.82e-05	0.000224	CbGpPWpGaD
Arsenic trioxide—JUN—Cellular Senescence—TP53—muscle cancer	5.82e-05	0.000224	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—FOXO1—muscle cancer	5.8e-05	0.000223	CbGpPWpGaD
Arsenic trioxide—JUN—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	5.7e-05	0.000219	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—ENO2—muscle cancer	5.69e-05	0.000218	CbGpPWpGaD
Arsenic trioxide—MAPK1—MAPK Signaling Pathway—TP53—muscle cancer	5.6e-05	0.000215	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—FOXO1—muscle cancer	5.57e-05	0.000214	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—CNR1—muscle cancer	5.56e-05	0.000214	CbGpPWpGaD
Arsenic trioxide—AKT1—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	5.48e-05	0.00021	CbGpPWpGaD
Arsenic trioxide—JUN—Circadian rythm related genes—TP53—muscle cancer	5.47e-05	0.00021	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cellular responses to stress—VEGFA—muscle cancer	5.43e-05	0.000208	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cellular Senescence—TP53—muscle cancer	5.42e-05	0.000208	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—ENO2—muscle cancer	5.41e-05	0.000208	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—CNR1—muscle cancer	5.4e-05	0.000207	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—FOXO4—muscle cancer	5.39e-05	0.000207	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—MED12—muscle cancer	5.39e-05	0.000207	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—FOXO1—muscle cancer	5.39e-05	0.000207	CbGpPWpGaD
Arsenic trioxide—IKBKB—MAPK Signaling Pathway—TP53—muscle cancer	5.36e-05	0.000206	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—HMGA1—muscle cancer	5.33e-05	0.000205	CbGpPWpGaD
Arsenic trioxide—MAPK3—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	5.31e-05	0.000204	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—KIT—muscle cancer	5.21e-05	0.0002	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—FOXO4—muscle cancer	5.18e-05	0.000199	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—HMGA1—muscle cancer	5.17e-05	0.000199	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cellular responses to stress—VEGFA—muscle cancer	5.16e-05	0.000198	CbGpPWpGaD
Arsenic trioxide—CCND1—Cell Cycle—TP53—muscle cancer	5.16e-05	0.000198	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cellular Senescence—TP53—muscle cancer	5.16e-05	0.000198	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—CNR1—muscle cancer	5.13e-05	0.000197	CbGpPWpGaD
Arsenic trioxide—MAPK1—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	5.05e-05	0.000194	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—FOXO4—muscle cancer	5.02e-05	0.000193	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—KIT—muscle cancer	5e-05	0.000192	CbGpPWpGaD
Arsenic trioxide—TXNRD1—Metabolism—PTGS2—muscle cancer	4.99e-05	0.000192	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—HMGA1—muscle cancer	4.92e-05	0.000189	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—ENO2—muscle cancer	4.91e-05	0.000189	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—FH—muscle cancer	4.88e-05	0.000187	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—KIT—muscle cancer	4.85e-05	0.000186	CbGpPWpGaD
Arsenic trioxide—AKT1—Adaptive Immune System—KIT—muscle cancer	4.8e-05	0.000185	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—FOXO4—muscle cancer	4.78e-05	0.000184	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—FOXO4—muscle cancer	4.78e-05	0.000184	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—FOXO4—muscle cancer	4.64e-05	0.000178	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cell Cycle, Mitotic—CDKN2A—muscle cancer	4.62e-05	0.000177	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—KIT—muscle cancer	4.62e-05	0.000177	CbGpPWpGaD
Arsenic trioxide—MAPK3—Axon guidance—VEGFA—muscle cancer	4.61e-05	0.000177	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—FOXO4—muscle cancer	4.57e-05	0.000176	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—MED12—muscle cancer	4.48e-05	0.000172	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—KIT—muscle cancer	4.42e-05	0.00017	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—FOXO4—muscle cancer	4.41e-05	0.000169	CbGpPWpGaD
Arsenic trioxide—JUN—Cellular responses to stress—TP53—muscle cancer	4.4e-05	0.000169	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cell Cycle, Mitotic—CDKN2A—muscle cancer	4.4e-05	0.000169	CbGpPWpGaD
Arsenic trioxide—MAPK1—Axon guidance—VEGFA—muscle cancer	4.38e-05	0.000168	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—KIT—muscle cancer	4.24e-05	0.000163	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cell Cycle—CDKN2A—muscle cancer	4.13e-05	0.000159	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—KIT—muscle cancer	4.1e-05	0.000158	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—MDM2—muscle cancer	4.1e-05	0.000158	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cellular responses to stress—TP53—muscle cancer	4.1e-05	0.000157	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—ENO2—muscle cancer	4.08e-05	0.000157	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—PTCH1—muscle cancer	4.05e-05	0.000156	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cell Cycle—MDM2—muscle cancer	4.01e-05	0.000154	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—FOXO1—muscle cancer	3.98e-05	0.000153	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—MDM2—muscle cancer	3.94e-05	0.000151	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cell Cycle—CDKN2A—muscle cancer	3.93e-05	0.000151	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	3.9e-05	0.00015	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cellular responses to stress—TP53—muscle cancer	3.9e-05	0.00015	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—FH—muscle cancer	3.9e-05	0.00015	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—PTCH1—muscle cancer	3.89e-05	0.00015	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—FOXO1—muscle cancer	3.82e-05	0.000147	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—MDM2—muscle cancer	3.82e-05	0.000147	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cell Cycle—MDM2—muscle cancer	3.81e-05	0.000146	CbGpPWpGaD
Arsenic trioxide—AKT1—Adaptive Immune System—MDM2—muscle cancer	3.78e-05	0.000145	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—PTCH1—muscle cancer	3.78e-05	0.000145	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	3.76e-05	0.000144	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—FOXO1—muscle cancer	3.71e-05	0.000142	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—MDM2—muscle cancer	3.64e-05	0.00014	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—PTCH1—muscle cancer	3.59e-05	0.000138	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—FOXO1—muscle cancer	3.53e-05	0.000136	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—FOXO1—muscle cancer	3.53e-05	0.000136	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—FOXO4—muscle cancer	3.49e-05	0.000134	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—MDM2—muscle cancer	3.48e-05	0.000134	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—PTCH1—muscle cancer	3.44e-05	0.000132	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—FOXO1—muscle cancer	3.43e-05	0.000132	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—CNR1—muscle cancer	3.42e-05	0.000131	CbGpPWpGaD
Arsenic trioxide—AKT1—Developmental Biology—VEGFA—muscle cancer	3.39e-05	0.00013	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—FOXO1—muscle cancer	3.38e-05	0.00013	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—FOXO4—muscle cancer	3.35e-05	0.000129	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—MDM2—muscle cancer	3.34e-05	0.000128	CbGpPWpGaD
Arsenic trioxide—AKT1—Hemostasis—VEGFA—muscle cancer	3.32e-05	0.000128	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—CNR1—muscle cancer	3.29e-05	0.000126	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—VEGFA—muscle cancer	3.29e-05	0.000126	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—FOXO1—muscle cancer	3.26e-05	0.000125	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—FOXO4—muscle cancer	3.25e-05	0.000125	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—MDM2—muscle cancer	3.23e-05	0.000124	CbGpPWpGaD
Arsenic trioxide—MAPK3—Hemostasis—VEGFA—muscle cancer	3.22e-05	0.000124	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	3.19e-05	0.000123	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—CNR1—muscle cancer	3.19e-05	0.000122	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—VEGFA—muscle cancer	3.13e-05	0.00012	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—FOXO4—muscle cancer	3.09e-05	0.000119	CbGpPWpGaD
Arsenic trioxide—MAPK1—Hemostasis—VEGFA—muscle cancer	3.07e-05	0.000118	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—KIT—muscle cancer	3.03e-05	0.000116	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—CNR1—muscle cancer	3.03e-05	0.000116	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	2.96e-05	0.000114	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—FOXO4—muscle cancer	2.96e-05	0.000114	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—KIT—muscle cancer	2.91e-05	0.000112	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CNR1—muscle cancer	2.9e-05	0.000111	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—KIT—muscle cancer	2.83e-05	0.000109	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—IGF2—muscle cancer	2.8e-05	0.000107	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—MED12—muscle cancer	2.76e-05	0.000106	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—KIT—muscle cancer	2.69e-05	0.000103	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—KIT—muscle cancer	2.69e-05	0.000103	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—IGF2—muscle cancer	2.69e-05	0.000103	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—KIT—muscle cancer	2.61e-05	0.0001	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—IGF2—muscle cancer	2.61e-05	0.0001	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—FOXO1—muscle cancer	2.57e-05	9.88e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—KIT—muscle cancer	2.57e-05	9.88e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—ENO2—muscle cancer	2.51e-05	9.66e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Hemostasis—TP53—muscle cancer	2.51e-05	9.65e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—KIT—muscle cancer	2.48e-05	9.54e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—IGF2—muscle cancer	2.48e-05	9.52e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—FOXO1—muscle cancer	2.47e-05	9.5e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—VEGFA—muscle cancer	2.45e-05	9.43e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Hemostasis—TP53—muscle cancer	2.44e-05	9.35e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—FH—muscle cancer	2.4e-05	9.22e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—FOXO1—muscle cancer	2.4e-05	9.21e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—MDM2—muscle cancer	2.39e-05	9.17e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—IGF2—muscle cancer	2.37e-05	9.11e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Hemostasis—TP53—muscle cancer	2.32e-05	8.9e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cell Cycle—TP53—muscle cancer	2.3e-05	8.83e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—MDM2—muscle cancer	2.3e-05	8.81e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—FOXO1—muscle cancer	2.28e-05	8.76e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	2.24e-05	8.6e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—MDM2—muscle cancer	2.23e-05	8.55e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—MED12—muscle cancer	2.2e-05	8.46e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cell Cycle—TP53—muscle cancer	2.19e-05	8.4e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—FOXO1—muscle cancer	2.18e-05	8.39e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—MDM2—muscle cancer	2.12e-05	8.14e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—MDM2—muscle cancer	2.12e-05	8.13e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—MDM2—muscle cancer	2.06e-05	7.89e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—PTGS2—muscle cancer	2.04e-05	7.85e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—MDM2—muscle cancer	2.03e-05	7.78e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—ENO2—muscle cancer	2.01e-05	7.71e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—PTGS2—muscle cancer	1.98e-05	7.61e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	1.97e-05	7.55e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—KIT—muscle cancer	1.96e-05	7.53e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—MDM2—muscle cancer	1.96e-05	7.51e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—PTGS2—muscle cancer	1.89e-05	7.24e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—KIT—muscle cancer	1.88e-05	7.24e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—TP53—muscle cancer	1.85e-05	7.12e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—KIT—muscle cancer	1.83e-05	7.02e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—KIT—muscle cancer	1.74e-05	6.68e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—PTGS2—muscle cancer	1.71e-05	6.57e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—KIT—muscle cancer	1.66e-05	6.39e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—MDM2—muscle cancer	1.54e-05	5.93e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—MDM2—muscle cancer	1.48e-05	5.7e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—MDM2—muscle cancer	1.44e-05	5.53e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—PTGS2—muscle cancer	1.42e-05	5.46e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—MDM2—muscle cancer	1.37e-05	5.26e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—MED12—muscle cancer	1.36e-05	5.21e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—MDM2—muscle cancer	1.31e-05	5.03e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—ENO2—muscle cancer	1.24e-05	4.75e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—VEGFA—muscle cancer	1.17e-05	4.5e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—VEGFA—muscle cancer	1.13e-05	4.33e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—VEGFA—muscle cancer	1.09e-05	4.2e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—VEGFA—muscle cancer	1.04e-05	3.99e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—VEGFA—muscle cancer	9.95e-06	3.82e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—TP53—muscle cancer	8.86e-06	3.4e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—PTGS2—muscle cancer	8.76e-06	3.36e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—TP53—muscle cancer	8.51e-06	3.27e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—TP53—muscle cancer	8.26e-06	3.17e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—TP53—muscle cancer	7.86e-06	3.02e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—TP53—muscle cancer	7.52e-06	2.89e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—PTGS2—muscle cancer	7e-06	2.69e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—PTGS2—muscle cancer	4.31e-06	1.66e-05	CbGpPWpGaD
